FlowMetric Life Sciences Inc., a globally recognized life sciences company, has joined HAPevolve as an industry partner. FlowMetric is proud to introduce VaxEffect, a unique and powerful test exclusively created to quantitatively assess and track now and over time, an individual’s immune response to all COVID-19 vaccines currently on the US market.

Initially available through health care providers, the unique VaxEffect test will provide a personalized, quantitative, and scientifically accurate measure of an individual’s COVID-19 specific antibody levels, either generated in response to a COVID-19 vaccine or after prior exposure to the SARS-CoV-2 virus. With simple, repeat testing you can track changes in your antibody levels to the vaccine you received through easy-to-read longitudinal reports, to better inform vaccine-based healthcare decisions as well as the potential need for booster vaccinations as they become available.

“The VaxEffect test will be especially important for patients with immune compromised conditions such as those fighting cancer, diabetes, auto-immune disorders, or those that are immunosuppressed due to organ transplantation who may not have generated a strong immune response to the vaccine” noted Grant Morgan, Ph.D., General Manager of VaxEffect and EVP of FlowMetric Life Sciences Inc.   

Unlike other antibody tests, VaxEffect is the first COVID serology test built on a multiparameter flow cytometry platform that is designed to differentiate between infection and vaccination based on an antibody profile. Using this proven, powerful, and precise technology, the VaxEffect Test is both 99%+ sensitive and 99%+ specific. 

The VaxEffect COVID-19 Vaccine Immune Response Test is a Laboratory Developed Test (LDT) that has been developed and validated by an experienced team of scientists in our FlowMetric Diagnostics’ CLIA-certified and CAP-accredited High Complexity Laboratory. FlowMetric diagnostics is a division of FlowMetric Life Sciences, Inc., a globally recognized life sciences company that provides vital medical information and analysis to empower pharmaceutical companies, researchers, doctors, hospitals and individuals to make accurate decisions that better protect the health and wellbeing of people everywhere. Combining deep expertise in immune response and multiparameter high-throughput flow cytometry, the company has pioneered an innovative full-spectrum service that supports many of the world's largest Pharmaceutical and Biotech companies in their drug development and vaccine initiatives.

HAPevolve identifies and creates valuable partnerships with a variety of businesses serving the health care community. By negotiating with its industry and endorsed partners on behalf of the Pennsylvania hospital and health care community at large, HAPevolve can offer members special benefits and discounts on innovative solutions that can save them both time and money.

To explore how VaxEffect can benefit your organization, contact Lori Mulholland, HAPevolve’s Director, Business Development, or Grant Morgan, VaxEffect, Executive Vice President & GM.